Kathryn E. Falberg

2011

In 2011, Kathryn E. Falberg earned a total compensation of $1.4M as Former Executive Vice President and Chief Financial Officer at Jazz Pharmaceuticals, a 33% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$300,000
Option Awards$707,080
Salary$377,635
Other$2,312
Total$1,387,027

Falberg received $707.1K in option awards, accounting for 51% of the total pay in 2011.

Falberg also received $300K in non-equity incentive plan, $377.6K in salary and $2.3K in other compensation.

Rankings

In 2011, Kathryn E. Falberg's compensation ranked 4,500th out of 10,747 executives tracked by ExecPay. In other words, Falberg earned more than 58.1% of executives.

ClassificationRankingPercentile
All
4,500
out of 10,747
58th
Division
Manufacturing
1,608
out of 3,960
59th
Major group
Chemicals And Allied Products
332
out of 1,033
68th
Industry group
Drugs
200
out of 781
74th
Industry
Pharmaceutical Preparations
157
out of 571
73rd
Source: SEC filing on June 12, 2014.

Falberg's colleagues

We found four more compensation records of executives who worked with Kathryn E. Falberg at Jazz Pharmaceuticals in 2011.

2011

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2011

Russell Cox

Jazz Pharmaceuticals

Chief Operating Officer

2011

Karen Wilson

Jazz Pharmaceuticals

Vice President, Finance and Principal Accounting Officer

2011

Carol Gamble

Jazz Pharmaceuticals

General Counsel

In-depth

You may also like